Building the New Bosco-Zeta Pharma (A) Harvard Case Solution & Analysis

Following the acquisition of the pharmaceutical Bosco Zeta AG, Chairman Bosco is not sure whether to merge the two companies, using only internal resources or take help Deloitte Consulting. Deloitte supports the overhaul of the organizational structure Bosco to accommodate Zeta, the company of one fifth Bosco. The Chairman is not known whether the adoption of worldwide product structure Zetas, or Zeta should be required to meet more geographical Bosco management and operating structure. This merger would be the largest in the 110-year history of Bosco, and it is crucial to benefit from it, particularly by linking the corporate culture and the achievement of the ambitious savings. "Hide
on LJ Bourgeois, Paul M. Hammaker, Nandini Bose, Yogesh Goswami, Sudeep Mathur, John Power Source: Darden School of Business 20 pages. Publication Date: November 13, 2008. Prod. #: UV1015-PDF-ENG

Building the New Bosco-Zeta Pharma (A) Case Solution Other Similar Case Solutions like

Building the New Bosco-Zeta Pharma (A)

Share This